Vitamin D₃, which is well known to maintain calcium homeostasis, plays an important role in various cellular processes. It regulates the proliferation and differentiation of several normal cells, including immune and neoplastic cells, influences the cell cycle, and stimulates cell maturation and apoptosis through a mechanism dependent on the vitamin D receptor. The involvement of vitamin D₃ in breast cancer development has been observed in numerous clinical studies. However, not all studies support the protective effect of vitamin D₃ against the development of this condition. Furthermore, animal studies have revealed that calcitriol or its analogs may stimulate tumor growth or metastasis in some breast cancer models. It has been postulated that the effect of vitamin D₃ on T helper (Th) 17 lymphocytes is one of the mechanisms promoting metastasis in these murine models. Herein we present a literature review on the existing data according to the interplay between vitamin D, Th17 cell and breast cancer. We also discuss the effects of this vitamin on Th17 lymphocytes in various disease entities known to date, due to the scarcity of scientific data on Th17 lymphocytes and breast cancer. The presented data indicate that the effect of vitamin D₃ on breast cancer development depends on many factors, such as age, menopausal status, or obesity. According to that, more extensive clinical trials and studies are needed to assess the importance of vitamin D in breast cancer, especially when no correlations seem to be obvious.

Background: Tyrosinase is a copper-dependent oxyreductase capable of catalyzing the oxidation of mono- and diphenols. Its activity is crucial in the biosynthetic pathway of melanin, the pigment responsible for the pigmentation of mammalian skin and fur, and protecting their skin from harmful UV radiation. Overproduction of this pigment leads to numerous pathological conditions, including the most severe form of skin cancer—malignant melanoma. Furthermore, tyrosinase produced in plant tissues leads to the browning of damaged vegetables and fruits. Therefore, the search for compounds that effectively and efficiently control tyrosinase activity is desirable for both pharmaceutical and food applications. Methods: A group of six boronate derivatives of thiosemicarbazones was synthesized, and their inhibitory properties against tyrosinase were determined. Furthermore, their ability to inhibit melanogenesis and proliferation in SK-MEL-3 and Hs294T cells was investigated. Docking simulations were performed to determine the nature of the inhibitor–protein interactions. Results: The tested inhibitors exhibited half-maximal inhibitory concentrations (IC₅₀) in the micromolar range. The best inhibitor, compound 6, had an IC₅₀ of 1.4 µM. The tested compounds exhibited poor selectivity for cell lines capable of high and low tyrosinase overexpression, with inhibitor 4 proving to be the most selective compound among those tested. Molecular modeling results indicate that the compounds with the highest activity against tyrosinase interact with the active cavity and the copper ions present within it via a boron moiety substituted on the aromatic ring of the thiosemicarbazones. Cell-based experiments indicated limited antiproliferative effects up to 100 µM across the tested lines. The compounds demonstrated weak antiproliferative effects in SK-MEL-3 and Hs-294T up to 100 µM. Conclusions: Our results show that the introduction of a boronic acid moiety is an alternative to carboxylic acid derivatives, improving the inhibitory activity of boron analogs (by fourfold) against fungal tyrosinase.